Table 3. Summary of adverse events from SLN or SLN biopsy with IFL.

Author and year of publication	Complications	SLN alone	SLN biopsy+IFL
van der Zee et al (2008); Brunner et al (2008); Achimas-Cadariu et al (2009); Moore et al (2008); Terada et al, 2006); Van den Eynden et al (2003); Johann et al (2008); Crosbie et al (2010)	Short-term adverse eventsa	Transient lymph oedema (13%), wound breakdown (11.7%) and wound cellulitis (4.5%)	Transient lymph oedema (39%), postoperative groin lymphocoele (5.5%), cellulitis arising in the labia majora (2.8%), wound cellulitis (9.5%) and seroma (4.3%), wound breakdown (34%) and wound cellulitis (21.3%), cellulitis (5.9%) and lymphocele (11.8%)
	Longer-term adverse eventsa	Lymphoedema (1.9%) and recurrent erysispelas (0.4%)	Wound infection (31%), wound dehiscence (25%), lymphocyst (22%) and chronic lymphoedema (16%), lymphoedema (25.2%) and recurrent erysipelas (16.2%)

Abbreviations: IFL=inguinofemoral lymphadenectomy; SLN=sentinel lymph node.

^aAs defined by the papers.